Longhorn Vaccines and Diagnostics Presents Data Demonstrating Neutralizing Activity of LHNVD-201 for Covid-19 and Influenza Co-Infections

Previous
Previous

New Study Shows Longhorn Vaccines and Diagnostics’ Universal Influenza Vaccine, LHNVD-105, Generates Broad and Durable Immune Responses in Animal Models

Next
Next

Longhorn Vaccines and Diagnostics to Present Durability Data of Peptide-Based Vaccine LHNVD-201 for Covid-19 and Influenza Co-Infections at 17th Vaccine Congress